Daunorubicin Citrate is a semi-synthetic anthracycline glycoside antibiotic obtained from Streptomyces with antineoplastic activity. Daunorubicin citrate intercalates DNA, which leads to inhibition of DNA and RNA synthesis, and consequently blocks cell division and results in apoptosis. It is grouped under the following drug class(es): Anthracyclines and Topoisomerase inhibitors. The directory classifies it as a commercial API with a fermentation-derived source/manufacturing origin. Other names for this substance include DaunoXome and Daunorubicin citrate. Its PubChem CID is 9961878.
Daunorubicin citrate
| CAS No | 371770-68-2 |
|---|---|
| Molecular Formula | C33H37NO17 |
| Molecular Weight | 719.6 g/mol |
| Synonyms | (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;2-hydroxypropane-1,2,3-tricarboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Daunorubicin Citrate is a semi-synthetic anthracycline glycoside antibiotic obtained from Streptomyces with antineoplastic activity. Daunorubicin citrate intercalates DNA, which leads to inhibition of DNA and RNA synthesis, and consequently blocks cell division and results in apoptosis.
The listed CAS number is 371770-68-2.
The listed molecular formula is C33H37NO17.
The listed molecular weight is 719.6 g/mol.
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;2-hydroxypropane-1,2,3-tricarboxylic acid.
The source lists DaunoXome and Daunorubicin citrate.